Background: Cardiovascular disease is the leading cause of death, and multiple
medications are often needed to control symptoms and risk factors. Little research has …

Objective: To describe the frequency and content of physician discussions about the cost
and acquisition of new medications. Study Design: Qualitative and quantitative study …

For Medicare beneficiaries who report having heart disease, drug coverage and type of
supplemental health insurance affect the likelihood of usage and costs of heart medications …

Objective Many trials of new therapies for cardiovascular disease include economic
measures to assess the impact of treatment on healthcare costs, however, it is difficult to …

Background Compliance with medical therapy is often compromised because patients
cannot afford to pay for medications. Inadequate physician knowledge of drug costs may …

Methods We identified 12,278 patients who were added to the Kaiser Permanente
Northwest CVD registry from 2000 to 2005. We observed patients until they died or left the …

Despite publication of evidence-based guidelines and numerous quality-improvement
efforts, studies have documented under use of effective cardiovascular medications in a …

PURPOSE: Little is known about whether health care providers are effectively identifying
patients who have difficulty covering the costs of out-of-pocket prescription medications. We …

BACKGROUND: Heart failure disproportionately affects older adults for whom multiple
medications are prescribed to prevent exacerbations and hospitalization. To target …

Purpose: To quantify the monetary value of medications provided to rural Alabamians
through provision of pharmaceutical manufacturer‐sponsored prescription assistance …